rs3134940
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP5BP4BA1
The NM_001136.5(AGER):c.964+208A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 804,572 control chromosomes in the GnomAD database, including 10,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely risk allele (no stars).
Frequency
Genomes: 𝑓 0.14 ( 1690 hom., cov: 33)
Exomes 𝑓: 0.16 ( 9088 hom. )
Consequence
AGER
NM_001136.5 intron
NM_001136.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.753
Genes affected
AGER (HGNC:320): (advanced glycosylation end-product specific receptor) The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847). [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP5
Variant 6-32182039-T-C is Pathogenic according to our data. Variant chr6-32182039-T-C is described in ClinVar as [Likely_risk_allele]. Clinvar id is 2582839.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_pathogenic, oryginal submission is: [Likely_risk_allele].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). . Strength limited to SUPPORTING due to the PP5.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGER | NM_001136.5 | c.964+208A>G | intron_variant | ENST00000375076.9 | NP_001127.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGER | ENST00000375076.9 | c.964+208A>G | intron_variant | 1 | NM_001136.5 | ENSP00000364217 | P1 |
Frequencies
GnomAD3 genomes AF: 0.142 AC: 21584AN: 152108Hom.: 1695 Cov.: 33
GnomAD3 genomes
AF:
AC:
21584
AN:
152108
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.130 AC: 16773AN: 129178Hom.: 1300 AF XY: 0.132 AC XY: 9340AN XY: 70526
GnomAD3 exomes
AF:
AC:
16773
AN:
129178
Hom.:
AF XY:
AC XY:
9340
AN XY:
70526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.157 AC: 102507AN: 652344Hom.: 9088 Cov.: 8 AF XY: 0.156 AC XY: 54006AN XY: 346268
GnomAD4 exome
AF:
AC:
102507
AN:
652344
Hom.:
Cov.:
8
AF XY:
AC XY:
54006
AN XY:
346268
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.142 AC: 21574AN: 152228Hom.: 1690 Cov.: 33 AF XY: 0.137 AC XY: 10217AN XY: 74416
GnomAD4 genome
AF:
AC:
21574
AN:
152228
Hom.:
Cov.:
33
AF XY:
AC XY:
10217
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
396
AN:
3478
ClinVar
Significance: Likely risk allele
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
COPD, severe early onset Pathogenic:1
Likely risk allele, no assertion criteria provided | research | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | Aug 10, 2023 | Differences in plasma levels of sRAGE according to genotypes - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at